Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

NCT00412594 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Hairy Cell Leukemia
Recurrent Hairy Cell Leukemia

Interventions

DRUG: Cladribine
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Rituximab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]